- Home
- TGTX vs SHAK Comparison
TGTX vs SHAK Comparison
Compare TGTX & SHAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGTX
- SHAK
- Stock Information
- Founded
- TGTX 1993
- SHAK 2004
- Country
- TGTX United States
- SHAK United States
- Employees
- TGTX N/A
- SHAK N/A
- Industry
- TGTX Biotechnology: Pharmaceutical Preparations
- SHAK Restaurants
- Sector
- TGTX Health Care
- SHAK Consumer Discretionary
- Exchange
- TGTX Nasdaq
- SHAK Nasdaq
- Market Cap
- TGTX 5.4B
- SHAK 5.6B
- IPO Year
- TGTX 1995
- SHAK 2015
- Fundamental
- Price
- TGTX $32.91
- SHAK $132.30
- Analyst Decision
- TGTX Strong Buy
- SHAK Buy
- Analyst Count
- TGTX 6
- SHAK 17
- Target Price
- TGTX $40.67
- SHAK $114.29
- AVG Volume (30 Days)
- TGTX 2.3M
- SHAK 672.1K
- Earning Date
- TGTX 11-04-2024
- SHAK 10-30-2024
- Dividend Yield
- TGTX N/A
- SHAK N/A
- EPS Growth
- TGTX N/A
- SHAK 50.44
- EPS
- TGTX N/A
- SHAK 0.20
- Revenue
- TGTX $264,790,000.00
- SHAK $1,210,167,000.00
- Revenue This Year
- TGTX $43.74
- SHAK $17.24
- Revenue Next Year
- TGTX $64.30
- SHAK $14.51
- P/E Ratio
- TGTX N/A
- SHAK $649.82
- Revenue Growth
- TGTX 39.53
- SHAK 16.38
- 52 Week Low
- TGTX $12.84
- SHAK $64.16
- 52 Week High
- TGTX $36.84
- SHAK $139.89
- Technical
- Relative Strength Index (RSI)
- TGTX 55.20
- SHAK 49.69
- Support Level
- TGTX $30.41
- SHAK $127.85
- Resistance Level
- TGTX $35.03
- SHAK $138.45
- Average True Range (ATR)
- TGTX 1.55
- SHAK 3.46
- MACD
- TGTX -0.33
- SHAK -1.15
- Stochastic Oscillator
- TGTX 51.78
- SHAK 10.83
About TGTX TG Therapeutics Inc.
TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. The company has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS). and the company is developing TG-1701 (BTK inhibitor) and TG-1801 (anti-CD47/CD19 bispecific mAb) for B-cell disorders which are under Phase 1 trial.
About SHAK Shake Shack Inc.
Shake Shack Inc is a roadside burger stand. It is serving a classic American menu of premium burgers, hot dogs, crispy chicken, frozen custard, crinkle-cut fries, shakes, beer, wine and more. The company's burgers are made with a whole-muscle blend of all-natural, hormone and antibiotic-free Angus beef, ground fresh daily, cooked to order and served on a non-genetically modified organism (GMO) potato bun. Its menu focuses on food and beverages, crafted from a range of classic American foods. The company serves draft Root Beer, seasonal freshly-squeezed lemonade, organic fresh brewed iced tea, cold brew coffee, organic apple juice, and Shack20 bottled water.